Adsys is a technology company.
Adsys has raised $150K across 1 funding round.
Adsys has raised $150K in total across 1 funding round.
Adsys has raised $150K in total across 1 funding round.
Adsys's investors include 100X.VC.
Adsys (Adsys Medtech Private Limited) is a health tech startup founded in 2021 and headquartered in Jaipur, Rajasthan, India, specializing in medical devices for rapid point-of-care blood diagnostics.[3][2][5] The company builds the Adsys One, an AI-powered device that revolutionizes blood testing by enabling quick, accurate diagnostics at the point of care, serving healthcare providers, clinics, and patients in need of streamlined care.[2][4] It addresses critical gaps in traditional diagnostics—such as slow lab results and accessibility issues—by leveraging cutting-edge hardware and software to deliver fast results, helping billions through improved patient outcomes and efficiency; with 25 employees, it shows early growth momentum in the burgeoning health tech sector.[3][4]
Adsys was founded in 2021 by Hardik Sharma and Apoorv Agarwal, who brought expertise to tackle inefficiencies in blood diagnostics.[3] The idea emerged from a mission to enable rapid blood diagnosis for billions, combining advanced AI, hardware, and software to create portable medical devices that streamline patient care in resource-limited settings.[2][4] Early traction stems from its focus on point-of-care innovation, positioning it as a promising player in India's health tech ecosystem shortly after launch.[3]
(Note: Search results do not detail community ecosystem or pricing, limiting depth here.)
Adsys rides the global point-of-care diagnostics trend, fueled by AI advancements, post-pandemic demand for rapid testing, and India's booming health tech market (projected to grow amid rising healthcare needs).[2][3][4] Timing is ideal with increasing smartphone penetration and AI integration enabling portable diagnostics in emerging economies, where market forces like aging populations and chronic disease prevalence favor accessible tools.[2] It influences the ecosystem by pushing affordable, AI-driven medtech, potentially lowering barriers for underserved regions and inspiring similar startups in Asia's health innovation wave.[3][4]
Adsys is poised for expansion through partnerships, regulatory approvals, and scaling Adsys One amid AI-health convergence and India's medtech push. Trends like decentralized care and edge AI will shape its path, evolving its influence from niche innovator to key player in global diagnostics. As a 2021 entrant with strong product focus, it exemplifies health tech's potential to transform lives—watch for funding rounds to fuel this momentum.[2][3]
Adsys has raised $150K across 1 funding round. Most recently, it raised $150K Seed in January 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 1, 2023 | $150K Seed | 100X.VC |